THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
162,564,564
Share change
-2,097,042
Total reported value
$981,884,925
Put/Call ratio
408%
Price per share
$6.04
Number of holders
140
Value change
-$9,661,276
Number of buys
69
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q4 2017

As of 31 Dec 2017, THERAPEUTICSMD INC - COM (TXMD) was held by 140 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 162,564,564 shares. The largest 10 holders included Bank of New York Mellon Corp, FMR LLC, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Vanguard Group Inc, FRANKLIN RESOURCES INC, STATE STREET CORP, Voya Investment Management LLC, and NORTHERN TRUST CORP. This page lists 140 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.